Accel Partners has allocated another $100 million for its Big Data Fund 2, and the firm has added Anthony Deighton, CTO of Qlikview, and Shlomo Kramer, CEO of Imperva, to its advisory council.
General Catalyst says its executive-in-residence program is clicking, pointing to the successful sale of energy startup CLEAResult to General Atlantic.
Digital coupon provider RetailMeNot has raised at least $265 million from venture investors in the past couple years to fund a spree of acquisitions and expand its market. Now, Austin Ventures and other backers are looking for a big return on investment from the company’s upcoming IPO.
The rate at which private equity firms exited their European investments slowed last year, a study showed on Monday, as economic uncertainty hit both new stock market listings and merger activity, Reuters reported.
After the weekend get up to speed on the latest happenings in the private equity universe with the lowdown on the Asian market, the CIA’s venture capital arm, JP Morgan ditching its PE unit and who’s coming and going in the world of biotech.
Trending on peHUB this week: BlackRock, Capital Dynamics, PIMCO, Deltek, Thoma Bravo, VC portfolio services, small-cap stocks, Right Now Economy, Amulet Capital, Harlem Globetrotters
Several PE firms, like TPG and Blackstone, have seen success for their companies in the IPO market this year. There have been 18 private equity-backed IPOs as of June 14, totaling $7.6 billion, Thomson Reuters says. And the biggest PE-backed IPO so far is…
JPMorgan Chase & Co said on Friday its private equity unit, One Equity Partners, will become independent, as the largest U.S. bank increases its focus on client businesses, Reuters reported.
This morning, there’s word that Apple plans to sell a $99 iPhone, Yahoo buys GhostBird Software and what happened the last time Rupert Murdoch got divorced.
When a company’s shares pop after an IPO, it’s common to hear griping that it left money on the table and should’ve priced shares higher. But one VC says nothing could be further from the truth.